59 results
S-8
ODYY
Odyssey Health, Inc.
5 Jan 24
Registration of securities for employees
4:28pm
to the satisfaction of applicable regulatory authorities.
We may be substantially dependent on third parties to conduct our clinical trials.
We may
8-K
ODYY
Odyssey Health, Inc.
29 Dec 23
Completion of Acquisition or Disposition of Assets
9:00am
nasal delivery device.
The closing of the Odyssey Purchased Asset was subject to the satisfaction of customary closing conditions, which included: (1 … ; and (6) Oragenics completion of its due diligence of the Purchased Assets to its satisfaction.
Item 9.01
Financial Statements and Exhibits
(d
8-K
eoygl95e0whbf498zx
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-2.1
z9d0l
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-99.1
kd2 3xsvs
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-10.1
vafpdn2gb60qbp9
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.3
fvj0jtk82f6r 7r6kg6t
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
l81 rv1uiv1mf2cid
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm